It has also been reported that MSA could inhibit tumor growth in colon cancer xenografts, and this inhibition was associated with a reduction of plasma tumor necrosis factor (TNFα)/IL-6 level (Zeng and Wu, 2015). Here, IL6 is linked to malignant colon neoplasm.